Cuprina Holdings (Cayman) LTD Logo

Cuprina Holdings (Cayman) LTD

Biomedical firm specializing in Maggot Debridement Therapy for wound care in Singapore & Hong Kong.

CUPR | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
BLOCK 1090, 169201 SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cuprina Holdings is a biomedical and biotechnology company specializing in the development and commercialization of innovative wound care solutions and cosmeceuticals. The company's primary focus is on Maggot Debridement Therapy (MDT), a biotherapy for chronic wounds like diabetic foot ulcers. Its flagship product, MEDIFLY, uses medical-grade sterile larvae for the non-surgical removal of necrotic tissue, offering a clinically-proven alternative to conventional treatments with demonstrated higher healing rates and faster debridement. The company's portfolio also includes collagen-based wound care products and a range of skin restoration balms and athletic care products. Cuprina primarily serves healthcare providers and patients in Singapore and Hong Kong.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cuprina Holdings (Cayman) LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cuprina Holdings (Cayman) LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cuprina Holdings (Cayman) LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden
XSPRAY
YD Bio Ltd Logo
Developing blood-based cancer detection and regenerative therapies for biopharma partners.
United States of America
YDES
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea
000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan
4531
Zai Lab Ltd Logo
Global biopharma firm developing therapies for oncology, immunology, neuroscience & infectious diseases.
United States of America
ZLAB
Zealand Pharma Logo
Developing innovative peptide medicines for metabolic and inflammatory diseases.
Denmark
ZEAL
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway
ULTI
Zenas BioPharma, Inc. Logo
Clinical-stage biopharma developing immunology-based therapies for autoimmune diseases.
United States of America
ZBIO
Zentalis Pharmaceuticals, Inc. Logo
Develops small molecule cancer drugs, led by a first-in-class oral WEE1 inhibitor for tumors.
United States of America
ZNTL

Talk to a Data Expert

Have a question? We'll get back to you promptly.